Vaccine vial maker Stevanato valued at over $5 bln in NYSE debut

  • 7/16/2021
  • 00:00
  • 15
  • 0
  • 0
news-picture

July 16 (Reuters) - Shares of Italy’s Stevanato Group S.p.A. , which makes glass vials for COVID-19 vaccines and other healthcare products, fell more than 20% in their New York Stock Exchange debut on Friday, giving the company a market capitalization of over $5 billion.

مشاركة :